Date: 10 September 2018
We are delighted to announce our new National Specialty Lead for Renal disorders – Professor David Wheeler.
David is Professor of Kidney Medicine at University College London, UK and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.
Professor Wheeler is a clinician scientist interested in the complications of chronic kidney disease, specifically those that increase the burden of cardiovascular disease and accelerate progression of kidney failure. He has participated in the development and running of several large-scale clinical trials testing lipid lowering regimens, calcimimetics and sodium glucose cotransporter 2 inhibitors in patients chronic kidney disease.
David is past president of the UK Renal Association and past chair of the UK Renal Registry. Locally he is clinical lead at the North Thames NIHR Clinical Research Network and heads up the clinical research team in the Department of Nephrology at the Royal Free Hospital.
Professor David Wheeler, NIHR National Specialty Lead for Renal Disorders, said:
“I am honoured to have been appointed to the role of NIHR National Speciality Lead for Renal disorders. Prof Phil Kalra will be a hard act to follow and I hope that we can build on his many achievements. "
“There is much to be done. The evidence base in Nephrology is slowly expanding as we address important questions with clinical studies. We should continue to promote these activities and increase the number of patients with kidney disease participating in well-designed high quality trials and observational studies. There are new and exciting therapies coming ‘online’ for several kidney diseases and we must facilitate the assessment of these new interventions in conjunction with our industry partners. We need to work more closely with colleagues in other specialities and with primary care, to help treat our patients at an early stage in their disease.
“We also need to make our trials more efficient and enhance patient engagement in trial design. Last but not least, we need to embed research into routine clinical practice in our specialty and encourage our colleagues to participate. I look forward to working towards these goals with the National Institute for Health Research.”
You may also be interested in